U.S. markets open in 5 hours 39 minutes

Midatech Pharma plc (MTP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3000+0.0400 (+1.77%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/21/2021
Current
Market Cap (intraday) 5
32.68M
Enterprise Value 3
22.53M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
96.30
Price/Book (mrq)
3.82
Enterprise Value/Revenue 3
125.16
Enterprise Value/EBITDA 7
-1.01

Trading Information

Stock Price History

Beta (5Y Monthly) 1.75
52-Week Change 358.04%
S&P500 52-Week Change 337.70%
52 Week High 37.0700
52 Week Low 31.2500
50-Day Moving Average 32.1044
200-Day Moving Average 32.1876

Share Statistics

Avg Vol (3 month) 32.24M
Avg Vol (10 day) 318.21M
Shares Outstanding 512.68M
Implied Shares Outstanding 6N/A
Float 10.1M
% Held by Insiders 10.21%
% Held by Institutions 111.71%
Shares Short (May 27, 2021) 4165.52k
Short Ratio (May 27, 2021) 40.97
Short % of Float (May 27, 2021) 4N/A
Short % of Shares Outstanding (May 27, 2021) 41.31%
Shares Short (prior month Apr 29, 2021) 4162.58k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 02, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 02, 2020

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,393.88%

Management Effectiveness

Return on Assets (ttm)-25.21%
Return on Equity (ttm)-168.89%

Income Statement

Revenue (ttm)343k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-3.98M
EBITDA -7.11M
Net Income Avi to Common (ttm)-22.19M
Diluted EPS (ttm)-3.6100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.55M
Total Cash Per Share (mrq)0.6
Total Debt (mrq)336k
Total Debt/Equity (mrq)5.00
Current Ratio (mrq)3.10
Book Value Per Share (mrq)0.54

Cash Flow Statement

Operating Cash Flow (ttm)-9.3M
Levered Free Cash Flow (ttm)-5.17M